{"AllianceGenome": "26837", "HGNC": "26837", "MIM": "300647", "_id": "139285", "_version": 1, "accession": {"genomic": ["AL355852.23", "CH471132.2", "CP068255.2", "NC_000023.11", "NC_060947.1", "NG_021345.1"], "protein": ["ABM60755.1", "BAC04964.1", "EAX05415.1", "NP_689637.3", "Q5JTC6.2"], "rna": ["AK097146.1", "AL833759.1", "DA939151.1", "EF186024.1", "NM_152424.4"], "translation": [{"protein": "BAC04964.1", "rna": "AK097146.1"}, {"protein": "ABM60755.1", "rna": "EF186024.1"}, {"protein": "NP_689637.3", "rna": "NM_152424.4"}]}, "alias": ["FAM123B", "OSCS", "WTX"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2024-02-16T17:00:00.000Z", "disease_label": "osteopathia striata with cranial sclerosis", "gcep": "Prenatal Gene Curation Expert Panel", "moi": "XL", "mondo": "MONDO:0010310", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_a0c6c307-2d6c-4893-8f52-5fc6a2e2d440-2024-02-16T170000.000Z", "sop": "SOP10"}}, "ensembl": {"gene": "ENSG00000184675", "protein": "ENSP00000364003", "transcript": "ENST00000374869", "translation": [{"protein": "ENSP00000364003", "rna": "ENST00000374869"}], "type_of_gene": "protein_coding"}, "entrezgene": "139285", "exons": [{"cdsend": 64193286, "cdsstart": 64189878, "chr": "X", "position": [[64185116, 64193384], [64205569, 64205708]], "strand": -1, "transcript": "NM_152424", "txend": 64205708, "txstart": 64185116}], "exons_hg19": [{"cdsend": 63413166, "cdsstart": 63409758, "chr": "X", "position": [[63404996, 63413264], [63425449, 63425588]], "strand": -1, "transcript": "NM_152424", "txend": 63425588, "txstart": 63404996}], "generif": [{"pubmed": 17204608, "text": "WTX, is inactivated in approximately one-third of Wilms tumors; it is inactivated by a monoallelic \"single-hit\" event targeting the single X chromosome in tumors from males and the active X chromosome in tumors from females"}, {"pubmed": 17510365, "text": "findings show that WTX, a protein encoded by a gene mutated in Wilms tumors, forms a complex with beta-catenin, AXIN1, beta-TrCP2 and APC; data provide a possible mechanistic explanation for the tumor suppressor activity of WTX"}, {"pubmed": 17620295, "text": "Deletion of the WTX gene is associated with Wilms' tumor with a balanced translocation t(X;18)"}, {"pubmed": 17925383, "text": "These data indicate that AMER1 controls the subcellular distribution of APC between membrane- and microtubule-associated pools, and might thereby regulate APC-dependent cellular morphogenesis, cell migration and cell-cell adhesion."}, {"pubmed": 18021721, "text": "Gene has a tumor suppressor function in Wilms tumors, and is involved in beta-catenin destruction."}, {"pubmed": 18311776, "text": "WT1 and WTX mutations occur with similar frequency, that they partially overlap in Wilms tumors, and that mutations in WT1, WTX, and CTNNB1 underlie the genetic basis of about one-third of Wilms tumors"}, {"pubmed": 18391980, "text": "Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors."}, {"pubmed": 18452086, "text": "there was not any evidence of WTX mutation in the 143 acute leukemia patients"}, {"pubmed": 18460646, "text": "WTX is rarely mutated in acute myeloid leukemia"}, {"pubmed": 18720004, "text": "Data indicate that WTX mutation is rare in colorectal, gastric, and hepatocellular carcinomas."}, {"pubmed": 19079258, "text": "The observed phenotypic discordance dependent upon whether a mutation is germline or occurs somatically suggests the existence of temporal or spatial constraints on the action of WTX during tumorigenesis."}, {"pubmed": 19137020, "text": "Mutations in WTX gene is associated with Wilms tumor."}, {"pubmed": 19351817, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19416806, "text": "WTX binds WT1 and enhances WT1-mediated transcription, suggesting a role for WTX in nuclear pathways implicated in the transcriptional regulation of cellular differentiation programs"}, {"pubmed": 19757195, "text": "inactivation of WTX appears to be a late event in tumorigenesis of nephroblastoma in a subgroup of nephroblastomas"}, {"pubmed": 19760609, "text": "WTX inactivation is associated with Wilms tumors"}, {"pubmed": 20209645, "text": "All investigated families diagnosed with Osteopathia striata with cranial sclerosis had WTX gene defects."}, {"pubmed": 20679664, "text": "WTX mutations can arise both early and late in Wilms tumour development"}, {"pubmed": 20696052, "text": "Mutations in the WTX-gene are associated with high-grade microsatellite instable colorectal cancers."}, {"pubmed": 20950377, "text": "Two novel WTX mutations underscore the unpredictability of male survival in osteopathia striata with cranial sclerosis."}, {"pubmed": 20956941, "text": "When gene expression changes mediated by wild-type WTX were compared with those affected by mutant WTX, WTX565 had a 55% overlap in differentially regulated genes, whereas WTX358 regulated only two genes affected by wild-type WTX."}, {"pubmed": 21498506, "text": "Amer1 exerts its negative regulatory role in Wnt signaling by acting as a scaffold protein for the beta-catenin destruction complex and promoting stabilization of Axin at the plasma membrane."}, {"pubmed": 22215675, "text": "WTX and NRF2 compete for binding to KEAP1, and thus loss of WTX leads to rapid ubiquitination and degradation of NRF2 and a reduced response to cytotoxic insult."}, {"pubmed": 22285752, "text": "WTX modulates p53 function, in part through regulation of its activator CBP/p300."}, {"pubmed": 22670894, "text": "Data indicate that osteopathia striata congenita with cranial sclerosis (OSCS) iscaused by germline deletions of in the X-linked gene WTX (FAM123B, AMER1)."}, {"pubmed": 22716240, "text": "Osteopathia striata with cranial sclerosis or Horan-Beighton syndrome is a rare X-linked dominant inherited bone dysplasia. Genetic analysis allowed the identification of maternally transmitted heterozygous nonsense c.1057C>T (p.R353X) WTX mutation."}, {"pubmed": 22800892, "text": "WTX mutations occur early in Wilms' tumor development, but at a low proportion. There was no evidence that WTX is the main cause of Wilms' tumor."}, {"pubmed": 23333300, "text": "Stat3 inhibits WTX expression through up-regulation of micro RNA-370 in Wilms tumor."}, {"pubmed": 24249259, "text": "WTX inactivation occurs in a wider variety of tumor types than previously appreciated and point to shared pathogenic mechanisms between a subset of pediatric malignancies."}, {"pubmed": 24265322, "text": "Data show that beta-arrestins regulate Wnt3a-induced low density lipoprotein receptor-related protein 6 (Lrp6) phosphorylation by the regulation of the membrane dynamics of Amer1."}, {"pubmed": 24459086, "text": "A nonsense mutation (c.1045C>T, p.Glu349*) in the WTX gene."}, {"pubmed": 26071483, "text": "Losses of AMER1 by other mechanisms apart from mutations."}, {"pubmed": 28326956, "text": "This study revealed no clinical or pathologic distinctions between Wilms tumor (WT) with and without WTX mutation. This similarity lends support to the concept of a common tumorigenic pathway between WT with aberrant WTX and those without."}, {"pubmed": 28893644, "text": "A novel heterozygous frameshift mutation in AMER1 was identified in a patient with osteopathia striata with cranial sclerosis."}, {"pubmed": 30939162, "text": "found that miR-4524b-5p could regulate the migration and invasion of cervical cancer by targeting WTX and that WTX could regulate the expression of beta-catenin"}, {"pubmed": 32365332, "text": "KIF23 activated Wnt/beta-catenin signaling pathway through direct interaction with Amer1 in gastric cancer."}, {"pubmed": 33265914, "text": "Deletion of Exon 1 in AMER1 in Osteopathia Striata with Cranial Sclerosis."}, {"pubmed": 34414661, "text": "The phenotypic spectrum of AMER1-related osteopathia striata with cranial sclerosis: The first Canadian cohort."}, {"pubmed": 35115027, "text": "IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer."}, {"pubmed": 37682704, "text": "AMER1 deficiency promotes the distant metastasis of colorectal cancer by inhibiting SLC7A11- and FTL-mediated ferroptosis."}], "genomic_pos": {"chr": "X", "end": 64205708, "ensemblgene": "ENSG00000184675", "start": 64185117, "strand": -1}, "genomic_pos_hg19": {"chr": "X", "end": 63425624, "start": 63404997, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0016055", "qualifier": "involved_in", "term": "Wnt signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0031398", "pubmed": 17510365, "qualifier": "involved_in", "term": "positive regulation of protein ubiquitination"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045732", "pubmed": 17510365, "qualifier": "involved_in", "term": "positive regulation of protein catabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060348", "qualifier": "involved_in", "term": "bone development"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0060612", "qualifier": "involved_in", "term": "adipose tissue development"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0060828", "qualifier": "involved_in", "term": "regulation of canonical Wnt signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0060828", "pubmed": 17925383, "qualifier": "involved_in", "term": "regulation of canonical Wnt signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0072161", "qualifier": "involved_in", "term": "mesenchymal cell differentiation involved in kidney development"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0090090", "pubmed": 17510365, "qualifier": "involved_in", "term": "negative regulation of canonical Wnt signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0090090", "pubmed": 21498506, "qualifier": "involved_in", "term": "negative regulation of canonical Wnt signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0090263", "pubmed": 21304492, "qualifier": "involved_in", "term": "positive regulation of canonical Wnt signaling pathway"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": [17925383, 21304492, 21498506], "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016604", "qualifier": "located_in", "term": "nuclear body"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0043231", "qualifier": "located_in", "term": "intracellular membrane-bounded organelle"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [17510365, 17925383, 21304492, 22682247, 24251807, 26496610], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0005546", "qualifier": "enables", "term": "phosphatidylinositol-4,5-bisphosphate binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0005546", "pubmed": 21304492, "qualifier": "enables", "term": "phosphatidylinositol-4,5-bisphosphate binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0005546", "pubmed": 17925383, "qualifier": "enables", "term": "phosphatidylinositol-4,5-bisphosphate binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0008013", "qualifier": "enables", "term": "beta-catenin binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008013", "pubmed": 21498506, "qualifier": "enables", "term": "beta-catenin binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0008013", "pubmed": 17510365, "qualifier": "enables", "term": "beta-catenin binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:1904713", "pubmed": 17510365, "qualifier": "enables", "term": "beta-catenin destruction complex binding"}]}, "homologene": {"genes": [[8364, 100495403], [9031, 422314], [9544, 707700], [9598, 465669], [9606, 139285], [9615, 606822], [9913, 539029], [10090, 72345], [10116, 501584]], "id": 51852}, "interpro": {"desc": "APC membrane recruitment protein", "id": "IPR019003", "short_desc": "AMER"}, "ipi": ["IPI00167391", "IPI00844450"], "map_location": "Xq11.2", "name": "APC membrane recruitment protein 1", "other_names": ["APC membrane recruitment protein 1", "RP11-403E24.2", "Wilms tumor gene on the X chromosome protein", "Wilms tumor on the X", "adenomatous polyposis coli membrane recruitment 1", "family with sequence similarity 123B", "protein FAM123B"], "pantherdb": {"HGNC": "26837", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1919595", "ortholog_type": "LDO", "panther_family": "PTHR22237", "taxid": 10090, "uniprot_kb": "Q7TS75"}, {"RGD": "1560322", "ortholog_type": "LDO", "panther_family": "PTHR22237", "taxid": 10116, "uniprot_kb": "D3ZCP6"}, {"Ensembl": "ENSGALG00000007599", "ortholog_type": "LDO", "panther_family": "PTHR22237", "taxid": 9031, "uniprot_kb": "F1NGE5"}, {"ZFIN": "ZDB-GENE-070719-2", "ortholog_type": "LDO", "panther_family": "PTHR22237", "taxid": 7955, "uniprot_kb": "F1RDM5"}], "uniprot_kb": "Q5JTC6"}, "pathway": {"reactome": [{"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-195253", "name": "Degradation of beta-catenin by the destruction complex"}, {"id": "R-HSA-195721", "name": "Signaling by WNT"}, {"id": "R-HSA-195721", "name": "Signaling by WNT"}, {"id": "R-HSA-196299", "name": "Beta-catenin phosphorylation cascade"}, {"id": "R-HSA-201681", "name": "TCF dependent signaling in response to WNT"}, {"id": "R-HSA-201681", "name": "TCF dependent signaling in response to WNT"}, {"id": "R-HSA-2262752", "name": "Cellular responses to stress"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-4641262", "name": "Disassembly of the destruction complex and recruitment of AXIN to the membrane"}, {"id": "R-HSA-4641262", "name": "Disassembly of the destruction complex and recruitment of AXIN to the membrane"}, {"id": "R-HSA-4791275", "name": "Signaling by WNT in cancer"}, {"id": "R-HSA-4839735", "name": "Signaling by AXIN mutants"}, {"id": "R-HSA-4839743", "name": "Signaling by CTNNB1 phospho-site mutants"}, {"id": "R-HSA-4839744", "name": "Signaling by APC mutants"}, {"id": "R-HSA-4839748", "name": "Signaling by AMER1 mutants"}, {"id": "R-HSA-5339716", "name": "Signaling by GSK3beta mutants"}, {"id": "R-HSA-5358747", "name": "CTNNB1 S33 mutants aren't phosphorylated"}, {"id": "R-HSA-5358749", "name": "CTNNB1 S37 mutants aren't phosphorylated"}, {"id": "R-HSA-5358751", "name": "CTNNB1 S45 mutants aren't phosphorylated"}, {"id": "R-HSA-5358752", "name": "CTNNB1 T41 mutants aren't phosphorylated"}, {"id": "R-HSA-5467337", "name": "APC truncation mutants have impaired AXIN binding"}, {"id": "R-HSA-5467340", "name": "AXIN missense mutants destabilize the destruction complex"}, {"id": "R-HSA-5467348", "name": "Truncations of AMER1 destabilize the destruction complex"}, {"id": "R-HSA-5663202", "name": "Diseases of signal transduction by growth factor receptors and second messengers"}, {"id": "R-HSA-597592", "name": "Post-translational protein modification"}, {"id": "R-HSA-8951664", "name": "Neddylation"}, {"id": "R-HSA-8953897", "name": "Cellular responses to stimuli"}, {"id": "R-HSA-9711123", "name": "Cellular response to chemical stress"}, {"id": "R-HSA-9755511", "name": "KEAP1-NFE2L2 pathway"}], "wikipathways": {"id": "WP4286", "name": "Genotoxicity pathway"}}, "pdb": ["4YJE", "4YJL", "4YK6"], "pfam": "PF09422", "pharmgkb": "PA145148904", "pharos": {"target_id": 10461, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF174388", "relationship": "is"}, {"id": "GNF185294", "relationship": "is"}, {"id": "GNF196200", "relationship": "is"}, {"id": "GNF207106", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF114594", "relationship": "is"}, {"id": "GNF154235", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000023.11", "NC_060947.1", "NG_021345.1"], "protein": "NP_689637.3", "rna": "NM_152424.4", "translation": {"protein": "NP_689637.3", "rna": "NM_152424.4"}}, "reporter": {"GNF1H": "gnf1h06973_at", "HG-U133_Plus_2": "1552882_a_at", "HTA-2_0": "TC0X001095.hg.1", "HuEx-1_0": ["4010602", "4010638", "4010640", "4010642", "4010644"], "HuGene-1_1": "8173232", "HuGene-2_1": "17111641"}, "retired": 160176, "summary": "The protein encoded by this gene upregulates trancriptional activation by the Wilms tumor protein and interacts with many other proteins, including CTNNB1, APC, AXIN1, and AXIN2. Defects in this gene are a cause of osteopathia striata with cranial sclerosis (OSCS). [provided by RefSeq, May 2010].", "symbol": "AMER1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1825263"}, "unigene": "Hs.314225", "uniprot": {"Swiss-Prot": "Q5JTC6"}}